Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1990 Aug;49(8):591–593. doi: 10.1136/ard.49.8.591

Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis.

R F Willkens 1, P A Leonard 1, D O Clegg 1, K G Tolman 1, J R Ward 1, C R Marks 1, M L Greene 1, G J Roth 1, C G Jackson 1, G W Cannon 1, et al.
PMCID: PMC1004170  PMID: 2396863

Abstract

The liver histology of 52 patients treated with intermittent low dose pulse methotrexate for rheumatoid arthritis was evaluated using a modification of the Roenigk grading system. Patients studied had had an average of 3.2 years of treatment or had received 1.7 g methotrexate. No patient had cirrhosis; 15 (29%) patients had evidence of mild fibrosis. Histological abnormalities were not predicted by liver function test changes, with the exception that hypoalbuminaemia occurred in 60% of those with grade IV (modified criteria) findings. The need for liver biopsy in patients with rheumatoid arthritis treated with methotrexate before two years or 1500 mg of treatment has not been established. Whether serial liver biopsies will be needed beyond this time has yet to be determined.

Full text

PDF
591

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen P. A., West S. G., O'Dell J. R., Via C. S., Claypool R. G., Kotzin B. L. Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study. Ann Intern Med. 1985 Oct;103(4):489–496. doi: 10.7326/0003-4819-103-4-489. [DOI] [PubMed] [Google Scholar]
  2. Aponte J., Petrelli M. Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate. Arthritis Rheum. 1988 Dec;31(12):1457–1464. doi: 10.1002/art.1780311201. [DOI] [PubMed] [Google Scholar]
  3. Ashton R. E., Millward-Sadler G. H., White J. E. Complications in methotrexate treatment of psoriasis with particular reference to liver fibrosis. J Invest Dermatol. 1982 Oct;79(4):229–232. doi: 10.1111/1523-1747.ep12500067. [DOI] [PubMed] [Google Scholar]
  4. Dahl M. G., Gregory M. M., Scheuer P. J. Liver damage due to methotrexate in patients with psoriasis. Br Med J. 1971 Mar 20;1(5750):625–630. doi: 10.1136/bmj.1.5750.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Geronemus R. G., Auerbach R., Tobias H. Liver biopsies upsilon liver scans in methotrexate-treated patients with psoriasis. Arch Dermatol. 1982 Sep;118(9):649–651. [PubMed] [Google Scholar]
  6. Healey L. A. The current status of methotrexate use in rheumatic diseases. Bull Rheum Dis. 1986;36(4):1–10. [PubMed] [Google Scholar]
  7. Hoffmeister R. T. Methotrexate therapy in rheumatoid arthritis: 15 years experience. Am J Med. 1983 Dec 30;75(6A):69–73. doi: 10.1016/0002-9343(83)90477-1. [DOI] [PubMed] [Google Scholar]
  8. Kremer J. M., Lee R. G., Tolman K. G. Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples. Arthritis Rheum. 1989 Feb;32(2):121–127. doi: 10.1002/anr.1780320202. [DOI] [PubMed] [Google Scholar]
  9. Lanse S. B., Arnold G. L., Gowans J. D., Kaplan M. M. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio. Dig Dis Sci. 1985 Feb;30(2):104–109. doi: 10.1007/BF01308193. [DOI] [PubMed] [Google Scholar]
  10. Lawrence C. M., Strange R. C., Summerly R., Scriven A. J., Elmahallawy M., Wood A., Fletcher P. J., Beckett G. J. Assessment of liver function using fasting bile salt concentrations in psoriasis prior to and during methotrexate therapy. Clin Chim Acta. 1983 Apr 25;129(3):341–351. doi: 10.1016/0009-8981(83)90038-4. [DOI] [PubMed] [Google Scholar]
  11. Lenler-Petersen P., Søgård H., Thestrup-Pedersen K., Zachariae H. Galactose tolerance test and methotrexate-induced liver fibrosis and cirrhosis in patients with psoriasis. Acta Derm Venereol. 1982;62(5):448–449. [PubMed] [Google Scholar]
  12. Menghini G. One-second biopsy of the liver--problems of its clinical application. N Engl J Med. 1970 Sep 10;283(11):582–585. doi: 10.1056/NEJM197009102831107. [DOI] [PubMed] [Google Scholar]
  13. Nyfors A. Liver biopsies from psoriatics related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics. Acta Pathol Microbiol Scand A. 1977 Jul;85(4):511–518. doi: 10.1111/j.1699-0463.1977.tb03882.x. [DOI] [PubMed] [Google Scholar]
  14. Podurgiel B. J., McGill D. B., Ludwig J., Taylor W. F., Muller S. A. Liver injury associated with methotrexate therapy for psoriasis. Mayo Clin Proc. 1973 Nov;48(11):787–792. [PubMed] [Google Scholar]
  15. Psoriasis-liver-methotrexate interactions. Arch Dermatol. 1973 Jul;108(1):36–42. [PubMed] [Google Scholar]
  16. Reese L. T., Grisham J. W., Aach R. D., Eisen A. Z. Effects of methotrexate on the liver in psoriasis. J Invest Dermatol. 1974 Jun;62(6):597–602. doi: 10.1111/1523-1747.ep12679887. [DOI] [PubMed] [Google Scholar]
  17. Roenigk H. H., Jr, Bergfeld W. F., St Jacques R., Owens F. J., Hawk W. A. Hepatotoxicity of methotrexate in the treatment of psoriasis. Arch Dermatol. 1971 Mar;103(3):250–261. [PubMed] [Google Scholar]
  18. Warin A. P., Landells J. W., Levene G. M., Baker H. A prospective study of the effects of weekly oral methotrexate on liver biopsy. Br J Dermatol. 1975 Sep;93(3):321–327. doi: 10.1111/j.1365-2133.1975.tb06498.x. [DOI] [PubMed] [Google Scholar]
  19. Weinblatt M. E., Coblyn J. S., Fox D. A., Fraser P. A., Holdsworth D. E., Glass D. N., Trentham D. E. Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med. 1985 Mar 28;312(13):818–822. doi: 10.1056/NEJM198503283121303. [DOI] [PubMed] [Google Scholar]
  20. Weinstein A., Marlowe S., Korn J., Farouhar F. Low-dose methotrexate treatment of rheumatoid arthritis. Long-term observations. Am J Med. 1985 Sep;79(3):331–337. doi: 10.1016/0002-9343(85)90312-2. [DOI] [PubMed] [Google Scholar]
  21. Zachariae H., Grunnet E., Sogaard H. Liver biopsy in methotrexate-treated psoriatics-a re-evalution. Acta Derm Venereol. 1975;55(4):291–296. [PubMed] [Google Scholar]
  22. Zachariae H., Kragballe K., Søgaard H. Methotrexate induced liver cirrhosis. Studies including serial liver biopsies during continued treatment. Br J Dermatol. 1980 Apr;102(4):407–412. doi: 10.1111/j.1365-2133.1980.tb06553.x. [DOI] [PubMed] [Google Scholar]
  23. Zachariae H., Kragballe K., Thestrup-Pedersen K., Kissmeyer-Nielsen F. HLA antigens in methotrexate-induced liver cirrhosis. Acta Derm Venereol. 1980;60(2):165–166. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES